XENE FY 2022 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-48.8% YoY

Gross Profit

$9M100.0% margin

Operating Income

-$129M-1368.9% margin

Net Income

-$125M-1328.9% margin

EPS (Diluted)

$-2.06

Cash Flow

Operating Cash Flow

-$98M

Free Cash Flow

-$101M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$754M

Total Liabilities

$33M

Stockholders' Equity

$721M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$18M	-48.8%
Gross Profit	$9M	$18M	-48.8%
Operating Income	-$129M	-$79M	-63.5%
Net Income	-$125M	-$79M	-58.9%